ProCE Banner Activity

CAR T-Cell Therapy in the Management of Relapsed/Refractory Follicular Lymphoma


Download this slideset from a live symposium for an expert overview of CAR T-cell therapy in follicular lymphoma, including the latest clinical data and advice on patient candidacy for and toxicity management with these agents.

Released: December 07, 2023



Julie M. Vose

Julie M. Vose, MD, MBA

Newmann M. and Milde E. Harris Professor
Chief, Hematology/Oncology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from Genentech, a member of the Roche Group; Genmab; Ipsen Biopharmaceuticals, Inc; and Regeneron Pharmaceuticals, Inc.

Genentech, a member of the Roche Group


Ipsen Biopharmaceuticals Inc

Regeneron Pharmaceuticals, Inc